Maiwei Biotech Investor Relations Activity Record List (2024/05/01)
Announcement of Resolutions of the 10th Meeting of the 2nd Supervisory Board of Maiwei Biotech
Announcement of Maiwei Biotech regarding the termination and re-provision of guarantees by the Company and its wholly-owned subsidiaries for wholly-owned subsidiaries
Notice of Maiwei Biotech on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Haitong Securities Co., Ltd.'s inspection opinion on the termination and re-provision of guarantees for wholly-owned subsidiaries by Maiwei (Shanghai) Biotechnology Co., Ltd. and its wholly-owned subsidiaries
Maiwei Biotech's announcement on the resignation of independent directors, nomination of independent directors, and adjustment of members of the 2nd Board of Directors Special Committee
Maiwei Biotech Independent Director Candidate Statement and Commitment (Qin Zhengyu)
Review opinions of the Nomination Committee of the 2nd Board of Directors of Maiwei Biotech on candidates for independent directors of the 2nd board of directors
Maiwei Biotech Independent Director Nominee Statement and Commitment (Qin Zhengyu)
Maiwei Biotech 2024 Second Extraordinary General Meeting of Shareholders Meeting Information
Maiwei Biotech voluntarily discloses an announcement on 9MW2821 to report clinical data and latest developments in the form of an oral report at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Announcement of Maiwei Biotech on its wholly-owned subsidiary opening a special account to raise funds and signing a quadripartite supervisory agreement for special fund raising account storage
Maiwei Biotech voluntarily discloses an announcement on the progress of clinical research on 9MW2821 for triple negative breast cancer indications (TNBC)
Maiwei Biotech Investor Relations Activity Record List (2024/04/01)
Maiwei Biotech Announces Resolutions of the 2023 Annual General Meeting of Shareholders
Maiwei Biotech 2024 First Quarter Report
Legal Opinion of Beijing Zhide (Shanghai) Law Firm on the 2023 Annual General Meeting of Shareholders of Maiwei (Shanghai) Biotechnology Co., Ltd.
Haitong Securities Co., Ltd.'s inspection opinions on the resignation of the deputy general manager and core technical personnel of Maiwei (Shanghai) Biotechnology Co., Ltd. and the addition of core technical personnel
Maiwei Biotech's announcement on the resignation of the company's deputy general manager and core technical staff and the addition of core technical personnel
Haitong Securities Co., Ltd. report on the 2023 continuous supervision site inspection report of Maiwei (Shanghai) Biotechnology Co., Ltd.
No Data